NCT03772002View on ClinicalTrials.gov

Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu

NAUnknownINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Hepatitis C, Chronic
Interventions
DIAGNOSTIC_TEST

HCV screening

HCV antibody and HCV RNA surveillance, anti-HCV treatment assessment

Trial Locations (2)

210008

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

213001

The Third Hospital of Changzhou, Changzhou

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER